Cargando…

Cost-effectiveness analysis of the treatment of mild and moderate Alzheimer’s disease in Brazil

OBJECTIVE: To perform a cost-effectiveness analysis of donepezil and rivastigmine therapy for mild and moderate Alzheimer’s disease (AD) from the perspective of the Brazilian Unified Health System. METHOD: A hypothetical cohort of 1,000 individuals of both sexes, aged >65 years, and diagnosed wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	da Silva, Luciana R., Vianna, Cid M.M., Mosegui, Gabriela B.G., Peregrino, Antônio A.F., Marinho, Valeska, Laks, Jerson
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Psiquiatria 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794128/ https://www.ncbi.nlm.nih.gov/pubmed/30427385 http://dx.doi.org/10.1590/1516-4446-2017-0021

Ejemplares similares

Cost of lost productivity from acute respiratory infections in South America
por: Mosegui, Gabriela B.G., et al.
Publicado: (2023)

Cost-effectiveness analysis and budgetary impact of the Cryptococcal Antigen Lateral Flow Assay (CRAG-LFA) implementation for the screening and diagnosis of cryptococcosis in asymptomatic people living with HIV in Brazil
por: Vianna, Cid Manso de Mello, et al.
Publicado: (2021)

Cost-effectiveness analysis and budgetary impact of anidulafungin treatment for patients with candidemia and other forms of invasive candidiasis in Brazil
por: Vianna, Cid Manso de Mello, et al.
Publicado: (2023)

Translation, cross-cultural adaptation, and psychometric properties of the Brazilian Portuguese version of the Consumer Financial Protection Bureau Financial Well-Being scale
por: Howat-Rodrigues, Anna Beatriz Carnielli, et al.
Publicado: (2021)

Recognizing Late Onset Frontotemporal Dementia with the DAPHNE scale: A case report
por: Martins, Leonardo Tafarello, et al.
Publicado: (2018)

Awareness of disease in dementia: Development of a multidimensional rating scale
por: Dourado, Marcia, et al.
Publicado: (2007)

Alzheimer disease neuropathology: understanding autonomic dysfunction
por: Engelhardt, Eliasz, et al.
Publicado: (2008)

Behavioral and psychological symptoms in dementia is not a unitary concept: A critical review with emphasis on Alzheimer’s disease
por: Laks, Jerson, et al.
Publicado: (2008)

PEG-asparaginase and native Escherichia coli L-asparaginase in acute lymphoblastic leukemia in children and adolescents: a systematic review
por: Medawar, Camile Valle, et al.
Publicado: (2020)

Probabilistic Cost-Effectiveness Analysis of Vaccination for Mild or Moderate Alzheimer’s Disease
por: Yang, Kuen-Cheh, et al.
Publicado: (2016)

Heterogeneity in Cost-Effectiveness Analysis of Vaccination for Mild and Moderate Alzheimer’s Disease
por: Lin, Chung-Hsien, et al.
Publicado: (2019)

Effect of TTP488 in patients with mild to moderate Alzheimer’s disease
por: Burstein, Aaron H, et al.
Publicado: (2014)

Rastreamento do câncer de mama: modelo de melhoria do acesso pelo uso de mamógrafos móveis
por: da Cunha, Gerson Nunes, et al.
Publicado: (2019)

Posturographic analysis of older adults without dementia and patients with Alzheimer’s disease: A cross-sectional study
por: Sant’Anna, Paula, et al.
Publicado: (2019)

Factors Associated with a Depressive Disorder in Alzheimer's Disease Are Different from Those Found for Other Dementia Disorders
por: Barca, Maria Lage, et al.
Publicado: (2012)

LRRK2 p.G2019S Mutation Is Not Common among Alzheimer’s Disease Patients in Brazil
por: Santos-Rebouças, Cíntia Barros, et al.
Publicado: (2009)

Neuropsychological Rehabilitation in Mild and Moderate Alzheimer’s Disease Patients
por: Ávila, Renata, et al.
Publicado: (2007)

Cortisol Reactivity to a physical stressor in Patients with Depression and Alzheimer's disease
por: Beserra, Ana, et al.
Publicado: (2022)

Characteristics of falls in mild and moderate Alzheimer’s disease
por: Kato-Narita, Eliane Mayumi, et al.
Publicado: (2009)

Towards a Brazilian dementia plan? Lessons to be learned from Europe
por: Engedal, Knut, et al.
Publicado: (2016)

In the September 2013 issue
por: Bottino, Cássio M.C., et al.
Publicado: (2013)

Neuroimaging criteria and cognitive performance in vascular mild cognitive impairment: A systematic review
por: Sudo, Felipe Kenji, et al.
Publicado: (2015)

Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
por: Seltzer, Ben
Publicado: (2010)

The conceptual relevance of assessment measures in patients with mild/mild-moderate Alzheimer's disease
por: Hartry, Ann, et al.
Publicado: (2018)

Elevated Glutamate and Glutamine Levels in the Cerebrospinal Fluid of Patients With Probable Alzheimer's Disease and Depression
por: Madeira, Caroline, et al.
Publicado: (2018)

Verbal fluency in Alzheimer's disease, Parkinson's disease, and major depression
por: de Araujo, Narahyana Bom, et al.
Publicado: (2011)

2009 International Meeting of the International Psychogeriatric Association Third Congress of the Brazilian Association of Geriatric Neuropsychiatry
por: Machado, João Carlos Barbosa, et al.
Publicado: (2008)

Brazilian version of the European Cross-Cultural Neuropsychological Test Battery (CNTB-BR): diagnostic accuracy across schooling levels
por: Araujo, Narahyana B., et al.
Publicado: (2020)

Different Patterns of White Matter Degeneration Using Multiple Diffusion Indices and Volumetric Data in Mild Cognitive Impairment and Alzheimer Patients
por: Alves, Gilberto Sousa, et al.
Publicado: (2012)

Estimating attrition in mild-to-moderate Alzheimer’s disease and mild cognitive impairment clinical trials
por: Ritchie, Marina, et al.
Publicado: (2023)

Reducing the Number of People with Dementia Through Primary Prevention in Mozambique, Brazil, and Portugal: An Analysis of Population-Based Data
por: Oliveira, Deborah, et al.
Publicado: (2019)

Enrichment factors for clinical trials in mild-to-moderate Alzheimer's disease
por: Ballard, Clive, et al.
Publicado: (2019)

Dysphagia is closely related to frailty in mild-to-moderate Alzheimer’s disease
por: Güner, Merve, et al.
Publicado: (2023)

Behavioral and Psychological Symptoms Impact Clinical Competence in Alzheimer’s Disease
por: Bertrand, Elodie, et al.
Publicado: (2017)

Correction: Different Patterns of White Matter Degeneration Using Multiple Diffusion Indices and Volumetric Data in Mild Cognitive Impairment and Alzheimer Patients
por: Alves, Gilberto Sousa, et al.
Publicado: (2013)

Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer’s disease
por: Rijpma, Anne, et al.
Publicado: (2015)

Vascular dementia and the cholinergic pathways
por: Engelhardt, Eliasz, et al.
Publicado: (2007)

Cerebrocerebellar system and Arnold’s bundle - A tractographic study: preliminary results
por: Engelhardt, Eliasz, et al.
Publicado: (2010)

The brain subcortical white matter and aging: A quantitative fractional anisotropy analysis
por: Engelhardt, Eliasz, et al.
Publicado: (2009)

Multiple-dose ponezumab for mild-to-moderate Alzheimer's disease: Safety and efficacy
por: Landen, Jaren W., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6863dosntq8vcndeb5blrk0kfa